- Felip, E., Metro, G., Soo, R. A., Wolf, J., Solomon, B. J., Tan, D. S., Ardizzoni, A., Lee, D. H., Sequist, L. V., Barlesi, F., Ponce-Aix, S., Abreu, D. R., Campelo, M. R. G., Sprauten, M., Djentuh, L. O., Smith, N., Jary, A., Belli, R., Glaser, S., … Yang, J. C.-H. (2024). Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer. European Journal of Cancer, 208. https://doi.org/10.1016/j.ejca.2024.114182
Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer
on 14 d'octubre de 2024
with No hi ha comentaris
Deixa un comentari